Insulet

Forecast & Rating25 analysts currently cover Insulet, with about 60.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $171.91, about 16.0% upside from the current price of $148.16. Price targets range from $144.00 to $275.00 — a wide spread, showing clear disagreement over just how much Insulet can rise. Historically, about 92.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Insulet closely still see room for the stock to rise. Data as of Aug 13, 2026; for reference only and not investment advice.